Névrite optique rétrobulbaire associée au traitement par infliximab

[1]  M. Siddiqui,et al.  Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis. , 2005, Drugs.

[2]  W. Gross,et al.  Remissionsinduktion mit Infliximab bei therapierefraktärer Wegenerscher Granulomatose - Verlaufsbeobachtung , 2004 .

[3]  K. Van Steen,et al.  Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. , 2003, Gastroenterology.

[4]  K. Schauenstein,et al.  Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis , 2003, Rheumatology International.

[5]  M. Ten Tusscher,et al.  Bilateral anterior toxic optic neuropathy and the use of infliximab , 2003, BMJ : British Medical Journal.

[6]  Y. El-Shabrawi,et al.  Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. , 2002, Ophthalmology.

[7]  J. Rosenbaum,et al.  Anti-TNF therapy for eye involvement in spondyloarthropathy. , 2002, Clinical and experimental rheumatology.

[8]  R. Sergott,et al.  Retrobulbar optic neuritis associated with infliximab. , 2002, Archives of ophthalmology.

[9]  D. Elewaut,et al.  Raynaud's phenomenon affecting the tongue of a patient with scleroderma , 2002, Annals of the rheumatic diseases.

[10]  [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis--Follow-up of six patients]. , 2002, Deutsche medizinische Wochenschrift.

[11]  W. Robinson,et al.  Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? , 2001, Arthritis and rheumatism.

[12]  P. Theodossiadis,et al.  Effect of infliximab on sight-threatening panuveitis in Behcet's disease , 2001, The Lancet.

[13]  Justine R. Smith,et al.  Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. , 2001, Arthritis and rheumatism.

[14]  D. Paty,et al.  TNF neutralization in MS , 1999, Neurology.

[15]  G. D'Haens,et al.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.

[16]  L. Kurland,et al.  Optic neuritis , 1995, Neurology.

[17]  R. Burde,et al.  Autoimmune optic neuropathy: evaluation and treatment. , 1988, Journal of neurology, neurosurgery, and psychiatry.